PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1997 | 1 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 7 |
| 2006 | 7 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 10 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 1 |
| 2018 | 17 |
| 2019 | 7 |
| 2020 | 64 |
| 2021 | 70 |
| 2022 | 49 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 16 |
| 2026 | 49 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Rev Med Virol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Mapping the Evidence for Oropouche Virus to Inform Research Prioritisation.
- Atabani SF, Bosworth M, Bobbins A, Evans B, Simmons Z, Pearce-Smith N, Tree JA, Dearman C, Hall Y, Duval D.
- Rev Med Virol. 2026 Nov;36(6):e70222. doi: 10.1002/rmv.70222.
- PMCID: PMC13695555
Atabani SF, et al.Rev Med Virol. 2026.PMCID: PMC13695555 -
Fluvoxamine and long COVID: Post-acute recovery.
- Reiersen AM, Zorumski CF, Lenze EJ.
- Rev Med Virol. Author manuscript. 2024 Jul;34(4):e2557. doi: 10.1002/rmv.2557.
- PMCID: PMC13695425
Reiersen AM, et al.Rev Med Virol. Author manuscript. 2024.PMCID: PMC13695425 -
Does COVID-19 Vaccination Protect Against Post-COVID Cardiovascular Conditions?
- Maria LFBS, Naves MCX, Duarte EC, Carvalho IPSF, Peixoto HM.
- Rev Med Virol. 2026 Nov;36(6):e70219. doi: 10.1002/rmv.70219.
- PMCID: PMC13653686
Maria LFBS, et al.Rev Med Virol. 2026.PMCID: PMC13653686 -
Regional and Temporal Dynamics of Dengue in Mexico (2020-2024): A Comprehensive Epidemiological Analysis.
- Taboada B, Zárate S, Díaz-González L, Hurtado JM.
- Rev Med Virol. 2026 Nov;36(6):e70216. doi: 10.1002/rmv.70216.
- PMCID: PMC13645368
Taboada B, et al.Rev Med Virol. 2026.PMCID: PMC13645368 -
Multiple Sclerosis and Viruses: « Liaisons Dangereuses ».
- Plavina S, Malakovska D, Kalnina J, Trapina I, Leonova E, Habib M, Schifmann S, Paramonovs J, Sjakste N, Vassetzky Y, Drouet E, Paramonova N.
- Rev Med Virol. 2026 Nov;36(6):e70212. doi: 10.1002/rmv.70212.
- PMCID: PMC13635778
Plavina S, et al.Rev Med Virol. 2026.PMCID: PMC13635778 -
Continuous Intravenous Acyclovir as Outpatient Parenteral Antimicrobial Therapy for HSV and VZV Neurological Infections: A Case Series With Pharmacokinetic and Cost Evaluation, and Review of Literature.
- Manders IG, van Tuinen EL, Weisfelt M, Goeijenbier M, Kalpoe JS, van Lelyveld SFL, van Gorp ECM, Hua KH.
- Rev Med Virol. 2026 Nov;36(6):e70206. doi: 10.1002/rmv.70206.
- PMCID: PMC13623296
Manders IG, et al.Rev Med Virol. 2026.PMCID: PMC13623296 -
Gut Microbiota Alterations in People Living With HIV: Dysbiosis, Immune Dysfunction and Therapeutic Perspectives.
- El Mheddeb S, El Kettani A, Bousfiha AA, Ezzikouri S, Ouladlahsen A.
- Rev Med Virol. 2026 Sep;36(5):e70202. doi: 10.1002/rmv.70202.
- PMCID: PMC13581345
El Mheddeb S, et al.Rev Med Virol. 2026.PMCID: PMC13581345 -
Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta-Analysis.
- Heen E, Øverbø J, Tveteraas IH, Solberg SL, Nøkleby H, Midtbø JE, Di Rusco F, Kasteng F, Ersson A, Andersson S, Johansen K, Juvet LK.
- Rev Med Virol. 2026 Sep;36(5):e70203. doi: 10.1002/rmv.70203.
- PMCID: PMC13581344
Heen E, et al.Rev Med Virol. 2026.PMCID: PMC13581344 -
Tobacco and Alcohol Exposure as Confounders in Assessing HPV-Related Cancer Trends After Male Vaccination.
- Marin-Lopez C, Akbari AR, Farhoud N, Aguirre CC, Alam B.
- Rev Med Virol. 2026 Sep;36(5):e70192. doi: 10.1002/rmv.70192.
- PMCID: PMC13563109
Marin-Lopez C, et al.Rev Med Virol. 2026.PMCID: PMC13563109 -
CRISPR-Engineered CAR-T Cell Therapy for Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: A Review of Emerging Therapeutic Prospects.
- Allehyani N, Alissa M, Alghamdi A, Alshehri MA, Abusalim GS, Alhegaili AS, Juraybi TN, Alsuwat MA.
- Rev Med Virol. 2026 Sep;36(5):e70199. doi: 10.1002/rmv.70199.
- PMCID: PMC13546091
Allehyani N, et al.Rev Med Virol. 2026.PMCID: PMC13546091